Bottom line
XRPR vs SPSM: the short answer
XRPR (REX-Osprey(TM) XRP ETF) and SPSM (State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF) are both etfs.
But SPSM is far broader, holding 613 positions to 4 for XRPR, so beyond the top names it adds exposure XRPR doesn't have.
SPSM is cheaper at 0.03% vs 75% — a difference of $7,497 a year per $10,000 invested.
Updated Nov 19, 2026
XRPR vs SPSM side by side
| XRPR | SPSM | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | SEI | SPDR (State Street) |
| Category | Crypto & Digital Assets | Small-Cap |
| Expense ratio | 75% | 0.03% |
| Annual cost per $10k | $7,500 | $3 |
| 10-yr cost on $10k (prospectus) | $930 | $39 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | — | +6.0% |
| 5-yr return (annualized) | — | +7.3% |
| 10-yr return (annualized) | — | +9.5% |
| Best quarter | — | +31.3% |
| Worst quarter | — | −32.7% |
| Net assets (fund) | $52.3M | $16.9B |
| Number of holdings | 4 | 613 |
| Portfolio turnover | 35% | 3% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
XRPR and SPSM share none of their top holdings.
XRPR top 10
- Xrp — 58.72%
- Coinshares Jersey Ltd — 39.46%
- First American Government Obli — 0.14%
SPSM top 10
- State Street Global Advisors — 5.85%
- FormFactor Inc — 0.68%
- Viasat Inc — 0.66%
- Molina Healthcare Inc — 0.65%
- Argan Inc — 0.60%
- BrightSpring Health Services Inc — 0.60%
- Element Solutions Inc — 0.59%
- MaxLinear Inc — 0.58%
- Krystal Biotech Inc — 0.53%
- ESCO Technologies Inc — 0.49%
FAQ
What is the difference between XRPR and SPSM?
XRPR (REX-Osprey(TM) XRP ETF) and SPSM (State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF) are both etfs. But SPSM is far broader, holding 613 positions to 4 for XRPR, so beyond the top names it adds exposure XRPR doesn't have.
Which is cheaper, XRPR or SPSM?
SPSM has the lower expense ratio (0.03%).
Should I own both XRPR and SPSM?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.